EP1942918A4 - Polyphenole aus schwarzem tee und ihre verwendungen - Google Patents

Polyphenole aus schwarzem tee und ihre verwendungen

Info

Publication number
EP1942918A4
EP1942918A4 EP06804045A EP06804045A EP1942918A4 EP 1942918 A4 EP1942918 A4 EP 1942918A4 EP 06804045 A EP06804045 A EP 06804045A EP 06804045 A EP06804045 A EP 06804045A EP 1942918 A4 EP1942918 A4 EP 1942918A4
Authority
EP
European Patent Office
Prior art keywords
polyphenols
black
black polyphenols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06804045A
Other languages
English (en)
French (fr)
Other versions
EP1942918A1 (de
Inventor
Yukihiko Hara
Nagini Siddavaram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Norin Co Ltd
Original Assignee
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Norin Co Ltd filed Critical Mitsui Norin Co Ltd
Publication of EP1942918A1 publication Critical patent/EP1942918A1/de
Publication of EP1942918A4 publication Critical patent/EP1942918A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP06804045A 2005-09-22 2006-09-21 Polyphenole aus schwarzem tee und ihre verwendungen Withdrawn EP1942918A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72000705P 2005-09-22 2005-09-22
PCT/US2006/037015 WO2007038291A1 (en) 2005-09-22 2006-09-21 Black tea polyphenols and uses thereof

Publications (2)

Publication Number Publication Date
EP1942918A1 EP1942918A1 (de) 2008-07-16
EP1942918A4 true EP1942918A4 (de) 2009-09-09

Family

ID=37900096

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06804045A Withdrawn EP1942918A4 (de) 2005-09-22 2006-09-21 Polyphenole aus schwarzem tee und ihre verwendungen

Country Status (3)

Country Link
EP (1) EP1942918A4 (de)
JP (1) JP2009509960A (de)
WO (1) WO2007038291A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5153319B2 (ja) * 2007-12-28 2013-02-27 三井農林株式会社 紅茶抽出物
JP2017002009A (ja) * 2015-06-15 2017-01-05 株式会社東洋新薬 免疫賦活剤
CN106420700B (zh) * 2016-11-15 2019-01-29 江南大学 一种牛血清白蛋白-多功能因子复合物
JP7413005B2 (ja) * 2019-12-24 2024-01-15 花王株式会社 非重合体カテキン類の安定化方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020176898A1 (en) * 1999-03-30 2002-11-28 Purdue Research Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
WO2005058340A1 (en) * 2003-12-17 2005-06-30 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US20050197495A1 (en) * 2004-03-03 2005-09-08 Naidu A. S. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050271603A1 (en) * 2002-07-26 2005-12-08 Stephanie Krammer Compositions comprising lactoferrin
WO2005016372A1 (en) * 2003-03-25 2005-02-24 Advitech Solutions Inc. Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020176898A1 (en) * 1999-03-30 2002-11-28 Purdue Research Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
WO2005058340A1 (en) * 2003-12-17 2005-06-30 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US20050197495A1 (en) * 2004-03-03 2005-09-08 Naidu A. S. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
CHANDRA MOHAN K V P ET AL: "Antiproliferative and apoptosis inducing effect of lactoferrin and black tea polyphenol combination on hamster buccal pouch carcinogenesis", BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 1760, no. 10, 1 October 2006 (2006-10-01), pages 1536 - 1544, XP025014996, ISSN: 0304-4165, [retrieved on 20061001] *
CHUNG FUNG-LUNG ET AL: "Tea and cancer prevention: Studies in animals and humans.", JOURNAL OF NUTRITION, vol. 133, no. 10, October 2003 (2003-10-01), pages 3268S - 3274S, XP002538537, ISSN: 0022-3166 *
ELATTAR TAWFIK M A ET AL: "Effect of Tea Polyphenols on Growth of Oral Squamous Carcinoma Cells In Vitro", ANTICANCER RESEARCH, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 20, no. 5B, 1 January 2000 (2000-01-01), pages 3459 - 3465, XP008091075, ISSN: 0250-7005 *
HSU STEPHEN D ET AL: "Chemoprevention of oral cancer by green tea", GENERAL DENTISTRY, vol. 50, no. 2, March 2002 (2002-03-01), pages 140 - 146, XP009120532, ISSN: 0363-6771 *
KATUNUMA N ET AL: "New apoptosis cascade mediated by lysosomal enzyme and its protection by epigallo-catechin gallate", ADVANCES IN ENZYME REGULATION, PERGAMON PRESS, OXFORD, GB, vol. 44, no. 1, 1 January 2004 (2004-01-01), pages 1 - 10, XP004671832, ISSN: 0065-2571 *
LAMBERT JOSHUA D ET AL: "Mechanisms of cancer prevention by tea constituents.", JOURNAL OF NUTRITION, vol. 133, no. 10, October 2003 (2003-10-01), pages 3262S - 3267S, XP002538535, ISSN: 0022-3166 *
LETCHOUMY P VIDJAYA ET AL: "In Vitro Antioxidative Potential of Lactoferrin and Black Tea Polyphenols and Protective Effects In Vivo on Carcinogen Activation, DNA Damage, Proliferation, Invasion, and Angiogenesis During Experimental Oral Carcinogenesis", ONCOLOGY RESEARCH, vol. 17, no. 5, 2008, pages 193 - 203, XP009120528, ISSN: 0965-0407 *
LETCHOUMY PARAMASIVAME VIDJAYA ET AL: "Comparative evaluation of antiproliferative, antiangiogenic and apoptosis inducing potential of black tea polyphenols in the hamster buccal pouch carcinogenesis model", JOURNAL OF CARCINOGENESIS, BIOMED CENTRAL, LONDON, GB, vol. 6, no. 1, 3 December 2007 (2007-12-03), pages 19, XP021037153, ISSN: 1477-3163 *
LI NING ET AL: "Tea preparations protect against DMBA-induced oral carcinogenesis in hamsters", NUTRITION AND CANCER, vol. 35, no. 1, 1999, pages 73 - 79, XP009120529, ISSN: 0163-5581 *
MOHAN ET AL: "In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells", CELL BIOLOGY INTERNATIONAL, ACADEMIC PRESS, GB, vol. 31, no. 6, 2 May 2007 (2007-05-02), pages 599 - 608, XP022057196, ISSN: 1065-6995 *
MOHAN K V P CHANDRA ET AL: "Combination chemoprevention of hamster buccal pouch carcinogenesis by bovine milk lactoferrin and black tea polyphenols", CANCER INVESTIGATION, vol. 26, no. 2, February 2008 (2008-02-01), pages 193 - 201, XP009120534, ISSN: 0735-7907 *
See also references of WO2007038291A1 *
SRINIVASAN P ET AL: "Therapeutic efficacy of green tea polyphenols on cellular thiols in 4-Nitroquinoline 1-oxide-induced oral carcinogenesis", CHEMICO-BIOLOGICAL INTERACTIONS, ELSEVIER SCIENCE IRLAND, IR, vol. 149, no. 2-3, 15 October 2004 (2004-10-15), pages 81 - 87, XP004610277, ISSN: 0009-2797 *
VARADHACHARY ATUL ET AL: "Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy", INTERNATIONAL JOURNAL OF CANCER, vol. 111, no. 3, 1 September 2004 (2004-09-01), pages 398 - 403, XP002538536, ISSN: 0020-7136 *
WOLF JEFFREY S ET AL: "Lactoferrin inhibits growth of malignant tumors of the head and neck", ORL, BASEL, vol. 65, no. 5, 1 September 2003 (2003-09-01), pages 245 - 249, XP009099443, ISSN: 0301-1569 *

Also Published As

Publication number Publication date
WO2007038291A1 (en) 2007-04-05
EP1942918A1 (de) 2008-07-16
JP2009509960A (ja) 2009-03-12

Similar Documents

Publication Publication Date Title
EP2124551A4 (de) Substituierte 1;3-dioxane und ihre verwendung
EP1868650A4 (de) Kovalente diabodies und ihre verwendung
EP2281006A4 (de) Vernetzer und ihre verwendung
EP1954140A4 (de) Glycerinlevulinatketale und ihre verwendung
EP2057185A4 (de) Polymyxinderivate und anwendungen davon
EP2010584A4 (de) Gepfropfte polymere und anwendungen davon
EP1773878A4 (de) Insulinoligomerkonjugate, formulierungen und anwendungen davon
EP1937824A4 (de) Trna-zusammensetzungen und deren verwendungen
BRPI0717367A2 (pt) Di-hidropirazolonas substituídas e sua aplicação.
EP2139490A4 (de) Bicyclische diazo-smac-mimetika und ihre anwendungen
EP2091552A4 (de) Stabilisierte maml-peptide und deren verwendungen
EP1856085A4 (de) Flavonoidverbindungen und verwendungen davon
EP2200613A4 (de) Phenazin-derivate und ihre verwendungen
EP1869106A4 (de) Janus-dendrimere und -dendrone
EP2012773A4 (de) Wirkstoffe und deren anwendungen
NL1031473A1 (nl) Cyclopentapyridine- en tetrahydrochinolinederivaten.
EP1824467A4 (de) Apogossypolon und dessen verwendungen
EP1838800A4 (de) Zusammensetzungen, redox-paare und deren verwendung
EP1753468A4 (de) Carboranylporphyrine und ihre verwendungen
NL1031627A1 (nl) Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan.
EP1848438A4 (de) Diaminophenothiazin-zusammensetzungen und deren verwendung
DE602006019344D1 (de) Differentialbegrenzer
EP2247303A4 (de) Hämostase-modulierende zusammensetzungen und ihre verwendungen
FR2917418B1 (fr) Composition de securite, non photocopiable et authentifiable
EP1778082A4 (de) Carboranylporphyrine und ihre verwendungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080418

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE FR GB

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/82 20060101AFI20080508BHEP

Ipc: A61K 31/35 20060101ALI20090729BHEP

Ipc: A61P 35/00 20060101ALI20090729BHEP

Ipc: A61K 38/16 20060101ALI20090729BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091104